Cite Filings / CGEM / 0001193125-23-109206
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

Cullinan Therapeutics, Inc. · Filed 2023-04-21 · Acc 0001193125-23-109206

Documents 1

  • DEF 14A Proxy Statement , d639531ddef14a.htm

Around this filing

  • 2024-05-16 DEF 14A Proxy Statement
  • 2023-04-21 DEFA14A Proxy Materials
  • 2023-04-21 DEF 14A Proxy Statement
  • 2023-04-20 4 Chief Medical Officer sold 392 shares at $10.71 ($4,198)
  • 2023-04-20 4 Chief Financial Officer sold 398 shares at $10.71 ($4,263)
  • 2023-04-20 4 Chief Development Officer sold 238 shares at $10.71 ($2,549)
  • 2022-04-29 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d639531ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…